These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 23921129)

  • 1. FcγRIIb mediates amyloid-β neurotoxicity and memory impairment in Alzheimer's disease.
    Kam TI; Song S; Gwon Y; Park H; Yan JJ; Im I; Choi JW; Choi TY; Kim J; Song DK; Takai T; Kim YC; Kim KS; Choi SY; Choi S; Klein WL; Yuan J; Jung YK
    J Clin Invest; 2013 Jul; 123(7):2791-802. PubMed ID: 23921129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TOM1 Regulates Neuronal Accumulation of Amyloid-β Oligomers by FcγRIIb2 Variant in Alzheimer's Disease.
    Gwon Y; Kam TI; Kim SH; Song S; Park H; Lim B; Lee H; Lee W; Jo DG; Jung YK
    J Neurosci; 2018 Oct; 38(42):9001-9018. PubMed ID: 30185465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amelioration of amyloid β-FcγRIIb neurotoxicity and tau pathologies by targeting LYN.
    Gwon Y; Kim SH; Kim HT; Kam TI; Park J; Lim B; Cha H; Chang HJ; Hong YR; Jung YK
    FASEB J; 2019 Mar; 33(3):4300-4313. PubMed ID: 30540497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
    Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ
    Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct pharmacological Akt activation rescues Alzheimer's disease like memory impairments and aberrant synaptic plasticity.
    Yi JH; Baek SJ; Heo S; Park HJ; Kwon H; Lee S; Jung J; Park SJ; Kim BC; Lee YC; Ryu JH; Kim DH
    Neuropharmacology; 2018 Jan; 128():282-292. PubMed ID: 29079294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway.
    Shankar GM; Bloodgood BL; Townsend M; Walsh DM; Selkoe DJ; Sabatini BL
    J Neurosci; 2007 Mar; 27(11):2866-75. PubMed ID: 17360908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FcγRIIb-SHIP2 axis links Aβ to tau pathology by disrupting phosphoinositide metabolism in Alzheimer's disease model.
    Kam TI; Park H; Gwon Y; Song S; Kim SH; Moon SW; Jo DG; Jung YK
    Elife; 2016 Nov; 5():. PubMed ID: 27834631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.
    Izzo NJ; Staniszewski A; To L; Fa M; Teich AF; Saeed F; Wostein H; Walko T; Vaswani A; Wardius M; Syed Z; Ravenscroft J; Mozzoni K; Silky C; Rehak C; Yurko R; Finn P; Look G; Rishton G; Safferstein H; Miller M; Johanson C; Stopa E; Windisch M; Hutter-Paier B; Shamloo M; Arancio O; LeVine H; Catalano SM
    PLoS One; 2014; 9(11):e111898. PubMed ID: 25390368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP.
    Wang Z; Jackson RJ; Hong W; Taylor WM; Corbett GT; Moreno A; Liu W; Li S; Frosch MP; Slutsky I; Young-Pearse TL; Spires-Jones TL; Walsh DM
    J Neurosci; 2017 Dec; 37(49):11947-11966. PubMed ID: 29101243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity.
    Izzo NJ; Xu J; Zeng C; Kirk MJ; Mozzoni K; Silky C; Rehak C; Yurko R; Look G; Rishton G; Safferstein H; Cruchaga C; Goate A; Cahill MA; Arancio O; Mach RH; Craven R; Head E; LeVine H; Spires-Jones TL; Catalano SM
    PLoS One; 2014; 9(11):e111899. PubMed ID: 25390692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. REDD1 Is Involved in Amyloid β-Induced Synaptic Dysfunction and Memory Impairment.
    Yi JH; Kwon H; Cho E; Jeon J; Lee J; Lee YC; Cho JH; Jun M; Moon M; Ryu JH; Kim JS; Choi JW; Park SJ; Lee S; Kim DH
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
    Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
    Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic and standardized comparison of reported amyloid-β receptors for sufficiency, affinity, and Alzheimer's disease relevance.
    Smith LM; Kostylev MA; Lee S; Strittmatter SM
    J Biol Chem; 2019 Apr; 294(15):6042-6053. PubMed ID: 30787106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-181a negatively modulates synaptic plasticity in hippocampal cultures and its inhibition rescues memory deficits in a mouse model of Alzheimer's disease.
    Rodriguez-Ortiz CJ; Prieto GA; Martini AC; Forner S; Trujillo-Estrada L; LaFerla FM; Baglietto-Vargas D; Cotman CW; Kitazawa M
    Aging Cell; 2020 Mar; 19(3):e13118. PubMed ID: 32087004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astrocytic glutamatergic transporters are involved in Aβ-induced synaptic dysfunction.
    Huang S; Tong H; Lei M; Zhou M; Guo W; Li G; Tang X; Li Z; Mo M; Zhang X; Chen X; Cen L; Wei L; Xiao Y; Li K; Huang Q; Yang X; Liu W; Zhang L; Qu S; Li S; Xu P
    Brain Res; 2018 Jan; 1678():129-137. PubMed ID: 29066369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal Protein Tyrosine Phosphatase 1B Hastens Amyloid β-Associated Alzheimer's Disease in Mice.
    Ricke KM; Cruz SA; Qin Z; Farrokhi K; Sharmin F; Zhang L; Zasloff MA; Stewart AFR; Chen HH
    J Neurosci; 2020 Feb; 40(7):1581-1593. PubMed ID: 31915254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synaptic deficits are rescued in the p25/Cdk5 model of neurodegeneration by the reduction of β-secretase (BACE1).
    Giusti-Rodríguez P; Gao J; Gräff J; Rei D; Soda T; Tsai LH
    J Neurosci; 2011 Nov; 31(44):15751-6. PubMed ID: 22049418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyk2/STAT3 signaling mediates beta-amyloid-induced neuronal cell death: implications in Alzheimer's disease.
    Wan J; Fu AK; Ip FC; Ng HK; Hugon J; Page G; Wang JH; Lai KO; Wu Z; Ip NY
    J Neurosci; 2010 May; 30(20):6873-81. PubMed ID: 20484629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bis(propyl)-cognitin Prevents β-amyloid-induced Memory Deficits as Well as Synaptic Formation and Plasticity Impairments via the Activation of PI3-K Pathway.
    Jiang L; Huang M; Xu S; Wang Y; An P; Feng C; Chen X; Wei X; Han Y; Wang Q
    Mol Neurobiol; 2016 Aug; 53(6):3832-3841. PubMed ID: 26160762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tooth Loss Induces Memory Impairment and Gliosis in App Knock-In Mouse Models of Alzheimer's Disease.
    Taslima F; Jung CG; Zhou C; Abdelhamid M; Abdullah M; Goto T; Saito T; Saido TC; Michikawa M
    J Alzheimers Dis; 2021; 80(4):1687-1704. PubMed ID: 33720883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.